Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat

NCT01837719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus Type 1 (HIV-1)

Interventions

DRUG: Atazanavir
DRUG: Cobicistat
DRUG: Atazanavir/Cobicistat FDC

Sponsor

Bristol-Myers Squibb